Stay informed with product updates, company news, and industry insights.
Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, backed by KKR, is pleased to announce the appointment of Teresa Abraham, PhD, as its new Vice President of Scientific and Technical Affairs
Biocrucible, a Sapphiros platform company dedicated to building the next generation of consumer diagnostics, announced the appointment of Per Grufman, Ph.D., as its Chief Executive Officer.
Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros's Chief Operating Officer ("COO") to President and Chief Executive Officer ("CEO").
Sapphiros has today completed the acquisition of Flexotronix Limited. Flexotronix have developed a high speed printed electronics manufacturing line using in-house proprietary conductive inks and printed components.
Sapphiros announced today that Mike Musgnug has joined the company as EVP Strategy for Sapphiros and CEO of GrapheneDX, a Sapphiros Group Company
The partnership aims to enable low-cost access to vaccines and diagnostics to advance public health in Africa and beyond.
Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies.
KR-backed platform building the next generation of diagnostic technologies, today announced the appointment of Mark Gladwell as Chief Operating Officer and Dr. Niall Armes as Chief Technology Officer
Biocrucible Ltd has received funding from the Bill & Melinda Gates Foundation to explore rapid molecular testing options for COVID-19 and other pathogens, which could be used in the home or in field settings.
For media inquiries, contact Becky Slack by emailing becky.slack@your-agenda.com or calling +44 7854 221568.